Sanuwave Health Shares Outstanding 2010-2024 | SNWVD
Sanuwave Health shares outstanding from 2010 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Sanuwave Health Annual Shares Outstanding
(Millions of Shares) |
| 2023 |
794 |
| 2022 |
549 |
| 2021 |
518 |
| 2020 |
378 |
| 2019 |
204 |
| 2018 |
150 |
| 2017 |
139 |
| 2016 |
108 |
| 2015 |
63 |
| 2014 |
48 |
| 2013 |
28 |
| 2012 |
21 |
| 2011 |
20 |
| 2010 |
13 |
| 2009 |
11 |
Sanuwave Health Quarterly Shares Outstanding
(Millions of Shares) |
| 2024-06-30 |
1,388 |
| 2024-03-31 |
1,162 |
| 2023-12-31 |
794 |
| 2023-09-30 |
893 |
| 2023-06-30 |
582 |
| 2023-03-31 |
575 |
| 2022-12-31 |
549 |
| 2022-09-30 |
561 |
| 2022-06-30 |
872 |
| 2022-03-31 |
525 |
| 2021-12-31 |
518 |
| 2021-09-30 |
518 |
| 2021-06-30 |
518 |
| 2021-03-31 |
518 |
| 2020-12-31 |
378 |
| 2020-09-30 |
385 |
| 2020-06-30 |
299 |
| 2020-03-31 |
296 |
| 2019-12-31 |
204 |
| 2019-09-30 |
211 |
| 2019-06-30 |
175 |
| 2019-03-31 |
157 |
| 2018-12-31 |
150 |
| 2018-09-30 |
152 |
| 2018-06-30 |
149 |
| 2018-03-31 |
140 |
| 2017-12-31 |
139 |
| 2017-09-30 |
139 |
| 2017-06-30 |
139 |
| 2017-03-31 |
138 |
| 2016-12-31 |
108 |
| 2016-09-30 |
116 |
| 2016-06-30 |
103 |
| 2016-03-31 |
75 |
| 2015-12-31 |
63 |
| 2015-09-30 |
63 |
| 2015-06-30 |
63 |
| 2015-03-31 |
63 |
| 2014-12-31 |
48 |
| 2014-09-30 |
51 |
| 2014-06-30 |
48 |
| 2014-03-31 |
40 |
| 2013-12-31 |
28 |
| 2013-09-30 |
32 |
| 2013-06-30 |
22 |
| 2013-03-31 |
21 |
| 2012-12-31 |
21 |
| 2012-09-30 |
21 |
| 2012-06-30 |
21 |
| 2012-03-31 |
21 |
| 2011-12-31 |
20 |
| 2011-09-30 |
21 |
| 2011-06-30 |
21 |
| 2011-03-31 |
16 |
| 2010-12-31 |
13 |
| 2010-09-30 |
13 |
| 2010-06-30 |
13 |
| 2010-03-31 |
13 |
| 2009-12-31 |
11 |
| 2009-09-30 |
11 |
| 2009-06-30 |
11 |
| 2009-03-31 |
11 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED PRODUCTS |
$0.056B |
$0.020B |
|
SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA.
|
